Genetic and Cellular Determinants of Arterial Thrombosis
Genetic and Cellular Determinants of Arterial Thrombosis
批准号:
6952046
负责人:
Roy L Silverstein
金额:
$253.05万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-24 至 2011-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Arterial thrombosis as the proximate cause of myocardial infarction, stroke, and limb gangrene remains the
most important cause of mortality and morbidity in the USA. Blood platelets play a critical role in initiating
arterial thrombi. The overall goal of this SCCOR is to discover genetic and cellular determinants of altered
platelet function in systemic inflammatory states, such as atherosclerosis and diabetes. We have assembled
a multidisciplinary team of clinical, basic and translational scientists and developed a Center with 6 scientific
projects and 6 cores. Project 1 will use in vitro assays, in vivo mouse genetic models, and human genetic
studies to examine the novel hypothesis that platelet glycoprotein CD36 mediates platelet hyper-reactivity
associated with atherosclerosis, diabetes, and inflammation. Project 2 will explore a critically important
clinical problem, platelet resistance to pharmacologic interventions, and will utilize a targeted human genetic
approach coupled to sophisticated in vitro assessment of platelet function. Project 3 will explore the
mechanistic role of platelet activating factor (PAF) in mediating the interface between inflammation and
thrombosis. Project 4 will study a clinical population of patients undergoing endovascular carotid stenting as
a model of the vulnerable plaque, focusing on developing novel imaging tools and biomarkers. Project 5 will
study leukocyte-platelet interactions, focusing on the role of the Mac-1 integrin in regulating thrombosis.
Project 6 will study patients with anti-phospholipid syndrome, an autoimmune disease that is an important
cause of thrombosis, especially in young women, to characterize determinants of thrombotic risk. Core A will
provide administrative support, Core B biostatistics support and Core C an infrastructure to support the
clinical research components of all 6 projects. Core D will provide high throughput human genotyping
services and Core E flow cytometry and mass spectrometry services. Core F will provide a curriculum and
career development support for physicians training in clinical thrombosis research in SCCOR laboratories.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic Role of CD36 in Thrombosis
-
批准号:8850653
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Mechanistic Role of CD36 in Thrombosis
-
批准号:8509398
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Mechanistic Role of CD36 in Thrombosis
-
批准号:9068225
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Mechanistic Role of CD36 in Thrombosis
-
批准号:8856644
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-angiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:7524585
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:7642363
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:8269065
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:7858475
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
INFLAMMATORY CELL SIGNALING BY CD36
-
批准号:7337249
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7337250
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7615095
-
项目类别:
-
资助金额:$228.17万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7297503
-
项目类别:
-
资助金额:$232.34万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Candidate Genes Affecting Adolescent Metabolic Syndrome
-
批准号:8100165
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7479739
-
项目类别:
-
资助金额:$228.21万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR
-
批准号:7493846
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7841709
-
项目类别:
-
资助金额:$228.12万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Genetic and Cellular Determinants of Arterial Thrombosis
-
批准号:7212067
-
项目类别:
-
资助金额:$252.04万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR
-
批准号:7226375
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
Genetic and Cellular Determinants of Arterial Thrombosis
-
批准号:7408541
-
项目类别:
-
资助金额:$252.36万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
Genetic and Cellular Determinants of Arterial Thrombosis
-
批准号:7615053
-
项目类别:
-
资助金额:$263.68万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
国内基金
海外基金
登录
查看更多内容
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
牙周炎对腹主动脉瘤的作用和机制研究
-
批准号:82370953
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:朱亚琴
-
依托单位:
衰老引起的大脑内稳态失调和神经炎症的机理与干预研究
-
批准号:92049303
-
项目类别:重大研究计划
-
资助金额:400.0万元
-
批准年份:2020
-
负责人:袁钧瑛
-
依托单位:
GSDMD介导的牙周膜干细胞焦亡在牙周炎致病机制中的作用
-
批准号:32000513
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈秦
-
依托单位:
脱硫弧菌通过肠肝轴诱导肝纤维化的机制研究
-
批准号:31970746
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:耿燕
-
依托单位:
炎性肠病中富亮氨酸重复激酶2对树突细胞迁移的作用及其机制
-
批准号:31801172
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2018
-
负责人:严静
-
依托单位:
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
-
批准号:31760328
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:周建奖
-
依托单位:
HDAC6调控巨噬细胞和中性粒细胞向炎症部位浸润的分子机理研究
-
批准号:31701216
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:谢松波
-
依托单位:
TRPV2在原发性肝癌中癌变作用的研究
-
批准号:81171933
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐迅迪
-
依托单位:
骨化三醇降低IgA肾病患者尿蛋白的机制研究
-
批准号:81100503
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:刘立军
-
依托单位: